Biosimilar bevacizumab on the PBS - information for health professionals and patients

Page last updated: 21 May 2021

A biosimilar brand of bevacizumab (Mvasi^®) will be listed on the PBS on 1 June 2021. Information about this listing, and about biosimilars, can be found on the Biosimilar Awareness Initiative web page. From 1 June 2021 Avastin^® will no longer be available on the PBS, and Mvasi^® will be the sole brand of bevacizumab available on the PBS.